Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice
Open Access
- 27 February 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 39 (3) , 635-644
- https://doi.org/10.1002/hep.20086
Abstract
Oncostatin M (OSM) is a member of the IL-6 family of cytokines. Mice deficient in the OSM receptor (OSMR-/-) showed impaired liver regeneration with persistent parenchymal necrosis after carbon tetrachloride (CCl4) exposure. The recovery of liver mass from partial hepatectomy was also significantly delayed in OSMR-/- mice. In contrast to wildtype mice, CCl4 administration only marginally induced expression of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 genes in OSMR-/- mice, correlating with the increased gelatinase activity of matrix metalloproteinase (MMP)-9 and matrix degradation in injured livers. The activation of STAT3 and expression of immediate early genes and cyclins were decreased in OSMR-/- liver, indicating that OSM signaling is required for hepatocyte proliferation and tissue remodeling during liver regeneration. We also found that CCl4 administration in IL-6-/- mice failed to induce OSM expression and that OSM administration in IL-6-/- mice after CCl4 injection induced the expression of cyclin D1 and proliferating cell nuclear antigen, suggesting that OSM is a key mediator of IL-6 in liver regeneration. Consistent with these results, administration of OSM ameliorated liver injury in wildtype mice by preventing hepatocyte apoptosis as well as tissue destruction. In conclusion, OSM and its signaling pathway may provide a useful therapeutic target for liver regeneration. (Hepatology 2004;39:635-644.)Keywords
This publication has 47 references indexed in Scilit:
- Interleukin-6 Protects against Fas-mediated Death by Establishing a Critical Level of Anti-apoptotic Hepatic Proteins FLIP, Bcl-2, and Bcl-xLPublished by Elsevier ,2001
- Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: Impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosisHepatology, 2001
- Cell Density-Dependent Regulation of Hepatic Development by a gp130-Independent PathwayBiochemical and Biophysical Research Communications, 2000
- Liver regenerationJournal of Hepatology, 2000
- Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient miceHepatology, 2000
- Differential regulation of extracellular matrix synthesis during liver regeneration after partial hepatectomy in ratsHepatology, 1999
- Adenovirus Vector Expressing Mouse Oncostatin M Induces Acute-Phase Proteins and TIMP-1 ExpressionIn Vivoin MiceJournal of Interferon & Cytokine Research, 1999
- gp130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINESAnnual Review of Immunology, 1997
- Two Signals Are Necessary for Cell Proliferation Induced by a Cytokine Receptor gp130: Involvement of STAT3 in Anti-ApoptosisImmunity, 1996
- Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administrationHepatology, 1991